🇺🇸 FDA

Drug profile · INN

atropine sulfate

RYJUNEA

approved S01FA01
US status
approved
Patents linked
8
News articles
0

Quick answer

atropine sulfate (RYJUNEA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous, intramuscular, subcutaneous, intrao. Current US regulatory status: approved.

Key facts

INN atropine sulfate
Brand RYJUNEA
Route INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAO
Formulation CAPSULE
ATC code S01FA01
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 12377068

    In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12357650

    Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12252714

    Halogenation of complex organic compounds

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12221462

    Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12163153

    Methods of manufacturing allogeneic CAR T cells

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12138276

    Halogenated psilocybin derivatives and methods of using

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12133840

    Halogenated xanthene composition and method for treating hematologic cancers

    Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12070460

    Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is atropine sulfate?

atropine sulfate (RYJUNEA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous, intramuscular, subcutaneous, intrao. Current US regulatory status: approved.

What is the brand name for atropine sulfate?

RYJUNEA is a marketed brand name for atropine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of atropine sulfate?

atropine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.